Cost of development services and research and development expenses
9,622
Amortization of intangible assets
728
Change in contingent consideration
-4,643
Selling, general and administrative expenses included credit losses of 2,724 for the year ended december 31, 2024 and (24,367 for the year ended december 31, 2023)
14,822
Share in net loss of associated companies
-8
Impairment of long-lived assets
18,338
Operating loss
-39,768
Credit loss on convertible loan receivable
0
Loss (profit) from deconsolidation of obi, korea, belgium, services and octomera (see note 3 and note 20)
4,480
Other income, net
606
Loss from extinguishment in connection with loans
-5,422
Financial expenses, net
-4,508
Inducement expense on conversion of convertible loans
4,304
Loss before income taxes
-48,916
Tax expense
97
Net loss
-49,013
Net (loss) income attributable to non-controlling interests
-848
Net loss attributable to orgenesis inc
-48,165
Basic EPS
11.44
Diluted EPS
11.44
Basic Average Shares
4,210,839
Diluted Average Shares
4,210,839
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Time Plot
Show the time plot by selecting a row from the table.